Introduction
Patients with chronic kidney disease (CKD) exhibit an increased risk of cardiovascular morbidity and mortality, with heart failure (HF) hospitalization being one of the most frequent cardiovascular events.
1 Chronic pressure and volume overload as well as non-haemodynamic factors, such as oxidative stress and inappropriate renin-angiotensin-aldosterone system activation, lead to the development of left ventricular (LV) systolic and diastolic dysfunction. 2 Left ventricular ejection fraction (LVEF), calculated prevalence of subtle LV systolic dysfunction, according to LV GLS, in patients with CKD and preserved LVEF is unknown. In addition, data on the prognostic value of LV GLS in this population with preserved LVEF are accumulating. 8 -10 Accordingly, the present study investigated the prevalence of impaired LV GLS in pre-dialysis and dialysis patients with preserved LVEF. Furthermore, the relationship between LV GLS and the combined endpoint of HF hospitalization and all-cause mortality and all-cause mortality alone, was investigated.
Methods

Patient population
From an ongoing registry of pre-dialysis and dialysis patients at the Leiden University Medical Centre, The Netherlands, 11 patients with preserved LVEF (≥50%) and New York Heart Association functional class I-IV, assessed by transthoracic echocardiography performed during haemodynamic stable conditions, were selected. All patients were diagnosed with CKD stage 3b-5 according to the 2012 clinical practice guideline for the evaluation and management of CKD by Kidney Disease: Improving Global Outcomes (KDIGO). 12 Patients younger than 18 years, patients with LVEF <50%, or in whom echocardiography was performed during hospitalization for HF, as well as patients with limited echocardiographic examination or inadequate image quality for off-line analysis, were excluded. The electronic medical records (HiX; ChipSoft, Amsterdam, The Netherlands) and the departmental cardiology information system (EPD-vision; Leiden University Medical Centre, Leiden, The Netherlands) were reviewed to collect the clinical data. Left ventricular GLS was measured with speckle tracking echocardiography. Left ventricular systolic dysfunction despite preserved LVEF was defined by a value of LV GLS lower than two standard deviations below the mean value of LV GLS derived from individuals without structural heart disease. 13 Patients were followed up for the occurrence of HF hospitalization and all-cause mortality at the Leiden University Medical Centre. The institutional review board approved this retrospective analysis of clinically acquired data and waived the need for patient written informed consent.
Clinical characteristics
Demographics, cardiovascular risk factors, medication use, and laboratory results were included as baseline clinical variables. Estimated glomerular filtration rate (eGFR) was calculated by the CKD Epidemiology Collaboration (CKD-EPI) equation as recommended.
12 Using the concentration of creatinine in a 24 h urine specimen and the pre-dialysis plasma creatinine concentration, residual renal function was calculated.
14 Ultrafiltration rate was calculated as follows: mean ultrafiltration volume (mL) of five sessions/session duration (h)/target weight (kg). Delta systolic blood pressure was calculated by subtracting pre-dialysis systolic blood pressure from post-dialysis systolic blood pressure. Estimated GFR was only measured in pre-dialysis patients, while residual renal function, dialysis type and dialysis vintage were measured in dialysis patients, and ultrafiltration rate and delta systolic blood pressure in haemodialysis patients. 3 Using the biplane Simpson's method, LV end-diastolic and end-systolic volumes and LVEF were measured from the apical four-and two-chamber views. 3 From the apical four-chamber view, left atrial volume was measured, using the disk summation technique, and indexed to body surface area. Tricuspid annular plane systolic excursion, as a measure of right ventricular function, was assessed in the focused apical four-chamber view of the right ventricle applying anatomical M-mode. 3 By measuring the width of the vena contracta, mitral regurgitation severity was graded semi-quantitatively, from colour-flow Doppler data. 15 Peak early diastolic (E) and late diastolic (A) wave velocities were measured using pulsed wave Doppler recordings of the mitral inflow. Lateral E' wave velocity of the mitral annulus was measured with colour-coded tissue Doppler imaging in the apical four-chamber view to assess LV relaxation. The E/E' ratio was derived as a measure of LV filling pressures.
Transthoracic echocardiography
16
To quantify LV GLS, two-dimensional speckle tracking echocardiography was used on standard routine gray scale images of apical four-, two-chamber and long-axis views.
17 Left ventricular GLS was provided by the software as the average peak systolic longitudinal strain value of the three apical views. Normally, LV GLS is reported as a negative value since it indicates the shortening of the myocardium relative to the original length; however, the magnitude (absolute value) of LV GLS is presented in this analysis. 17 Patients were divided into two groups according to LV GLS >15.2% (more preserved) and LV GLS ≤15.2% (more impaired), a cut-off value obtained from 2 standard deviations below the mean value of LV GLS derived from healthy controls. 13 
Follow-up
The national death registry and case records were reviewed for the occurrence of all-cause mortality during follow-up. In addition, HF hospitalization during follow-up after the index echocardiography was registered through case record review. Finally, the occurrence of renal transplant during follow-up was recorded since this event impacts significantly on the outcome of these patients.
Statistical analysis
Categorical variables were presented as numbers and percentages and continuous variables as the mean ± standard deviation. Continuous variables without a normal distribution were presented as the median and interquartile range (IQR). Patients were divided into two groups: LV GLS >15.2% and LV GLS ≤15.2%. Categorical variables were compared between groups using the chi-square test or Fisher's exact test and continuous variables were compared between groups using the Student's t-test or Mann-Whitney U test, as appropriate. Correlations between continuous variables were tested with the Pearson correlation test. To explore the independent correlates of reduced LV systolic function (LV GLS ≤15.2%), multivariate binary logistic regression was applied. Cumulative event-free survival rates for the composite endpoint of all-cause mortality and HF hospitalization and all-cause mortality alone were calculated using the Kaplan-Meier method. Comparisons between patients with LV GLS >15.2% and patients with LV Figure 1 Prevalence of left ventricular (LV) systolic dysfunction based on LV global longitudinal strain (GLS) value ≤15.2% in pre-dialysis and dialysis patients with preserved LV ejection fraction (LVEF). Despite LVEF ≥50%, 32% of patients showed LV systolic dysfunction according to strain analysis. Examples of two patients with and without LV systolic dysfunction are shown in the lower panels: despite having the same LVEF, the patient in the left has severely reduced LV GLS, while the patient in the right shows normal LV GLS.
GLS ≤15.2% were performed based on the log-rank test. Univariable and multivariable Cox proportional hazard analyses were performed to evaluate the independent association between LV GLS and the composite endpoint of all-cause mortality and HF hospitalization. A two-sided P-value of <0.05 was considered to be statistically significant. Statistical analyses were performed using the SPSS software, version 20.0 (IBM Corp., Armonk, NY, USA).
Results
Patient population
Of 200 pre-dialysis and dialysis patients (65% men, mean age 60 ± 14 years) with LVEF ≥50%, 136 (68%) had LV GLS >15.2% and 64 (32%) showed LV GLS ≤15.2% ( Figure 1 ). Patients with LV GLS ≤15.2% had more advanced CKD, shorter dialysis vintage, higher heart rate, and higher prevalence of associated co-morbidities compared to patients with LV GLS >15.2% (Table 1) . Furthermore, patients with LV GLS ≤15.2% had a higher use of oral anticoagulation and lower albumin level compared to patients with LV GLS >15.2% ( Table 1) .
On echocardiography, patients with LV GLS ≤15.2% had thicker interventricular septum and posterior wall and larger LV mass index compared to patients with LV GLS >15.2%. Left ventricular end-systolic diameter and volume were larger in patients with LV GLS ≤15.2% compared to patients with LV GLS >15.2%. As per inclusion criteria, all patients had LVEF ≥50%; however, patients with LV GLS ≤15.2% showed lower LVEF compared to patients with LV GLS >15.2% (61% vs. 65%). Early diastolic mitral annular velocity (E') was lower and LV filling pressures were higher in . Independent correlates of left ventricular global longitudinal strain ≤15.2% Table 3 shows the results of the univariable and multivariable analyses. The univariable analysis included variables that were known to influence LV GLS and were significantly different between patients with LV GLS ≤15.2% and patients with LV GLS >15.2%. The variables significantly associated with LV GLS ≤15.2% at univariable analysis were included in the multivariable analysis. Interventricular septum thickness in diastole, posterior wall thickness in diastole, LV end-systolic volume and lateral E' wave velocity were not included in the multivariable model to avoid multi-collinearity. Only increased heart rate and larger LV mass index were independently associated with LV GLS ≤15.2%.
Prognostic implications of left ventricular systolic dysfunction despite preserved ejection fraction
A total of 93 (47%) patients underwent renal transplantation, 17 (9%) were admitted with HF, and 55 (28%) died during a median follow-up of 33 months (IQR 17-62 months). Sixteen patients died of cardiovascular causes. The Kaplan-Meier curves of the composite endpoint of all-cause mortality and HF hospitalization for patients with LV GLS ≤15.2% vs. patients with LV GLS >15.2% are depicted in Figure 2 . Patients with LV GLS 
Continuous data are presented as mean ± standard deviation, or median (interquartile range). Categorical data are presented as numbers (% Figure 3 . Patients with LV GLS ≤15.2% showed significantly worse prognosis compared to patients with LV GLS >15.2%; the cumulative event-free survival at 36 months was 71% and 84%, respectively (log-rank P = 0.040). The number of terminal events for the composite endpoint of all-cause mortality and HF hospitalization and all-cause mortality alone are presented in the supplementary material online, Table S1 . On univariable analyses, age, renal transplantation, CKD stage, diastolic blood pressure, lateral E/E', and LV GLS were associated with the composite endpoint of all-cause mortality and HF hospitalization ( Table 4) . On multivariable analysis, LV GLS was independently associated with increased risk of all-cause mortality and HF hospitalization after correcting for age, renal transplantation, CKD stage, diastolic blood pressure, lateral E/E', and LV mass index ( Table 4) .
Discussion
The present study demonstrates that the prevalence of LV systolic dysfunction as assessed by LV GLS in pre-dialysis and dialysis patients with preserved LVEF is relatively high. Increased heart rate and LV mass index were independently associated with impaired LV GLS. Furthermore, pre-dialysis and dialysis patients with preserved LVEF but impaired LV GLS exhibit increased rates . 
Impaired left ventricular global longitudinal strain despite preserved left ventricular ejection fraction in chronic kidney disease patients
In the present study, over one-third of patients with CKD and preserved LVEF showed LV systolic dysfunction, defined by LV GLS ≤15.2%. CKD has been previously shown to be independently associated with lower values of LV GLS in patients with HF and preserved LVEF. 6 The prevalence of reduced LV GLS in patients with CKD and preserved LVEF has not been extensively reported and varies significantly in previous studies.
18 -20 Among 88 haemodialysis patients with LVEF ≥50% and no significant valvular heart disease, HF or chronic atrial fibrillation, 17% had LV systolic dysfunction, defined by LV GLS ≤15%. 18 In addition, in 106 patients with a broad range of CKD (varying from stage 1 to 5), LVEF ≥55% and no history of cardiovascular diseases or symptoms, 24% had LV systolic dysfunction, defined by LV GLS <16%. 19 This prevalence was as high as 89% in 48 African American haemodialysis patients with preserved LVEF (≥50%) and no significant valvular heart disease when using a cut-off value of LV GLS <16% to define LV systolic dysfunction. 20 The different cut-off values used to define preserved LVEF and differences in patient characteristics (from racial differences, various stages of CKD, to differences in risk factors and cardiovascular co-morbidities) have certainly contributed to the differences in the reported prevalence. In addition, the associated cardiovascular co-morbidities (after excluding significant valvular heart disease) and the changing loading conditions of the patients may have contributed to such high prevalence. In the present population, patients with reduced LV GLS more frequently had coronary artery disease, which may have influenced the prevalence of LV systolic dysfunction. In addition, increased heart rate and larger LV mass index were independently associated with LV GLS ≤15.2%, after adjusting for various clinical and echocardiographic variables. The pressure and volume overload associated with advanced CKD stages and alterations in calcium-phosphate metabolism and sympathetic innervation induce cardiovascular remodelling that affect the heart and vessels. The arterial system is characterized by increased stiffness and reduced compliance that may induce LV hypertrophy while the presence of arteriovenous access conduits leads to a hyperdynamic circulation that increases heart rate. 2 The underlying pathophysiology is an increase of the extracellular matrix and fibrosis. This cardiovascular remodelling maintains the LVEF in a (supra-) normal range. However, at long-term follow-up, among patients who develop HF symptoms, some may show reduced LVEF while, in other patients, LVEF remains within the normal range. The present study shows that LV GLS detects these changes at an early phase of the disease. Therefore, LV GLS may be an important echocardiographic tool to identify patients at elevated risk for future development of HF. 
Prognostic implications of reduced left ventricular global longitudinal strain in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction
Studies evaluating the occurrence of HF hospitalization and all-cause mortality events in patients with CKD with preserved LVEF stratified according to LV GLS are limited.
18 -20 In a recent study, Liu et al. 18 reported higher cumulative all-cause mortality rates in haemodialysis patients with preserved LVEF but LV GLS ≤15% compared to patients with LV GLS >15% (40% vs. 15%, log-rank P = 0.001) over a mean follow-up of 26 ± 10 months. In contrast, there were no differences in HF hospitalization events.
18
In a larger population, including a broad range of CKD stages (from 1 to 5), Panoulas et al. 19 showed that patients with LV GLS <16% had higher rates of major adverse cardiac events (including all-cause mortality, acute coronary syndromes, stable angina requiring revascularization, and HF hospitalization) as compared to patients with LV GLS ≥16% (11% vs. 6% at 12-month follow-up, P = 0.038). The present study reports on the prevalence and prognostic implications of LV systolic dysfunction despite preserved LVEF in the largest population of pre-dialysis and dialysis patients . 
Limitations
This study has several limitations including its retrospective design and relative small sample size. Since only pre-dialysis and dialysis patients with a clinically indicated echocardiography were included in this analysis, there may be a selection bias. Secondly, pre-dialysis and dialysis patients with a previous myocardial infarction were not excluded. However, any form of coronary artery disease (prior myocardial infarction or prior coronary revascularization) did not affect the independent association between LV GLS ≤15.2% and outcome. Furthermore, patients with significant valvular heart disease were not excluded, which may have affected LV GLS, although the prevalence of moderate/severe mitral regurgitation was not significantly different between patients with LV GLS ≤15.2% and LV GLS >15.2%. In addition, LV GLS may have been influenced by loading conditions, despite the fact that echocardiography was performed after dialysis and ultrafiltration rate and delta systolic blood pressure were not significantly different between patients with LV GLS ≤15.2% and LV GLS >15.2%. The low number of cardiovascular mortality events precluded the analysis of the independent association between LV GLS and this endpoint.
Conclusion
In pre-dialysis and dialysis patients with preserved LVEF, the prevalence of LV systolic dysfunction as defined by an LV GLS ≤15.2% is as high as 32%. Increased heart rate and LV mass index were independently associated with impaired LV GLS. Pre-dialysis and dialysis patients with preserved LVEF and LV GLS ≤15.2% have worse prognosis with significantly higher rates of HF hospitalization and all-cause mortality as compared to patients with LV GLS >15.2%. Left ventricular GLS was independently associated with an increased risk of all-cause mortality and HF hospitalization.
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